期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
胰岛素聚酯纳米粒的制备及药效学研究 被引量:22
1
作者 马利敏 张强 +1 位作者 李玉珍 顾忠伟 《中国药学杂志》 CAS CSCD 北大核心 2001年第1期38-42,共5页
:目的 探讨ε 己内酯 D ,L 丙交酯嵌段共聚物纳米粒 (PCLA NP)作为新型药物载体的可能性。方法 采用双乳化溶媒蒸发法制备了胰岛素嵌段共聚物纳米粒 (INS PCLA NP) ,透射电镜考察其形态 ;HPLC测定胰岛素的包封率 ,并考察了影响纳米粒... :目的 探讨ε 己内酯 D ,L 丙交酯嵌段共聚物纳米粒 (PCLA NP)作为新型药物载体的可能性。方法 采用双乳化溶媒蒸发法制备了胰岛素嵌段共聚物纳米粒 (INS PCLA NP) ,透射电镜考察其形态 ;HPLC测定胰岛素的包封率 ,并考察了影响纳米粒粒径及包封率的各种因素 ;应用抗体捕捉实验验证纳米粒的载药机制 ;考察INS PCLA NP的体外释药特性 ;建立了糖尿病大鼠模型 ,通过葡萄糖氧化酶法 (GOD PAP)测定血糖浓度来评价INS PCLA NP经皮注后的降血糖作用 ,并计算INS PCLA NP的药理生物利用度 (pharmacologicalbioavailability ,PBA)。结果 INS PCLA NP的平均粒径为 16 7.3nm ;纳米粒的平均包封率为 37.79 % ;PVA浓度和超声时间对粒径及包封率影响显著 ;抗体捕捉实验证实被包封的胰岛素大部分 (约 5 3 % )存在于纳米粒的表面 ;INS PCLA NP的体外释药曲线分为两相 :突释释药相和缓释平台相 ;药效学研究表明 ,12u·kg-1的INS PCLA NP经皮下给药后即有明显的降血糖作用 ,药理生物利用度为 74.76 %。结论 PCLA 展开更多
关键词 ε-己内酯-D L-丙交酯嵌段共聚物 胰岛素 降血糖作用 聚酯纳米粒
下载PDF
Surface-modulated and thermoresponsive polyphosphoester nanoparticles for enhanced intracellular drug delivery 被引量:2
2
作者 LI Yang WANG Feng +3 位作者 SUN TianMeng DU JinZhi YANG XianZhu WANG Jun 《Science China Chemistry》 SCIE EI CAS 2014年第4期579-585,共7页
The chemical structure of end groups influenced the phase transition temperature of thermoresponsive polymers. We demonstrated a strategy for the preparation of the pH/thermo-responsive polymeric nanoparticles via sub... The chemical structure of end groups influenced the phase transition temperature of thermoresponsive polymers. We demonstrated a strategy for the preparation of the pH/thermo-responsive polymeric nanoparticles via subtle modification of end groups of thermoresponsive polymer segments with a carboxyl group and revealed its potential application for enhanced intracellular drug delivery. By developing a polymeric nanoparticle composed of poly(aliphatic ester) as the inner core and thermoresponsive polyphosphoester as the outer shell, we showed that end groups of thermoresponsive polyphosphoester segments modified by carboxyl groups exhibited a pH/thermo-responsive behavior due to the hydrophilic to hydrophobic transitions of the end groups in response to the pH. Moreover, by encapsulating doxorubicin into the hydrophobic core of such pH/thermo-responsive polymer nanoparticles, their intracellular delivery and cytotoxicity to wild-type and drug-resistant tumor cells were significantly enhanced through the phase-transition-dependent drug release that was triggered by endosomal/lysosomal pH. This novel strategy and the multi-responsive polymer nanoparticles achieved by the subtle chain-terminal modification of thermoresponsive polymers provide a smart platform for biomedical applications. 展开更多
关键词 THERMORESPONSIVE drug release POLYPHOSPHOESTER drug resistance
原文传递
Biotinylated polyurethane-urea nanoparticles for targeted theranostics in human hepatocellular carcinoma 被引量:2
3
作者 Genoveva MorraI-Ruiz Pedro Melgar-Lesmes +2 位作者 Andrea Lopez-Vicente Conxita Solans Maria Jose Garcia-Celma 《Nano Research》 SCIE EI CAS CSCD 2015年第5期1729-1745,共17页
Over the past years, significant efforts have been devoted to explore novel drug delivery and detection strategies for simultaneous therapy and diagnostics. The development of biotinylated polyurethane-urea nanopartic... Over the past years, significant efforts have been devoted to explore novel drug delivery and detection strategies for simultaneous therapy and diagnostics. The development of biotinylated polyurethane-urea nanoparticles as theranostic nanocarriers for targeted drug and plasmid delivery, for fluorescence detection of human hepatocellular carcinoma cells, is described herein. These targeted nanoparticles are specifically designed to incorporate biotin into the polymeric matrix, since many tumor types overexpress receptors for biotin as a mechanism to boost uncontrolled cell growth. The obtained nanoparticles were spherical, exhibited an average diameter ranging 110-145 nm, and showed no cytotoxicity in healthy endothelial cells. Biotinylated nanoparticles are selectively incorporated into the perinuclear and nuclear area of the human hepatocellular carcinoma cell line, HepG2, in division, but not into growing, healthy, human endothelial cells. Indeed, the simultaneous incorporation of the anticancer drugs, phenoxodiol or sunitinib, together with plasmid DNA encoding green fluorescent protein, into these nanoparticles allows a targeted pharmacological antitumor effect and furthermore, selective transfection of a reporter gene, to detect these cancer cells. The combined targeted therapy and detection strategy described here could be exploited for liver cancer therapy and diagnostics, with a moderate safety profile, and may also be a potential tool for other types of cancer. 展开更多
关键词 cancer therapy DNA NANOPARTICLES POLYURETHANE THERANOSTICS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部